202 related articles for article (PubMed ID: 35117329)
21. TETology: Epigenetic Mastermind in Action.
Seethy A; Pethusamy K; Chattopadhyay I; Sah R; Chopra A; Dhar R; Karmakar S
Appl Biochem Biotechnol; 2021 Jun; 193(6):1701-1726. PubMed ID: 33694104
[TBL] [Abstract][Full Text] [Related]
22. The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis.
Wang R; Gao X; Yu L
BMC Cancer; 2019 Apr; 19(1):389. PubMed ID: 31023266
[TBL] [Abstract][Full Text] [Related]
23. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
Poole CJ; Lodh A; Choi JH; van Riggelen J
Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
[TBL] [Abstract][Full Text] [Related]
24. Ten-Eleven-Translocation Genes in Cancer.
Wang Y; Wang X; Lu J
Cancer Treat Res; 2023; 190():363-373. PubMed ID: 38113007
[TBL] [Abstract][Full Text] [Related]
25. Induction of active demethylation and 5hmC formation by 5-azacytidine is TET2 dependent and suggests new treatment strategies against hepatocellular carcinoma.
Sajadian SO; Ehnert S; Vakilian H; Koutsouraki E; Damm G; Seehofer D; Thasler W; Dooley S; Baharvand H; Sipos B; Nussler AK
Clin Epigenetics; 2015; 7(1):98. PubMed ID: 26366235
[TBL] [Abstract][Full Text] [Related]
26. [Effect of cadmium on TET enzymes and DNA methylation changes in human embryonic kidney cell].
Li J; Li W; Yin H; Zhang B; Zhu W
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Sep; 49(9):822-7. PubMed ID: 26733141
[TBL] [Abstract][Full Text] [Related]
27. Dysregulation of DNA epigenetic modulators during prostate carcinogenesis in an eastern Indian patient population: Prognostic implications.
Banerjee A; Bardhan A; Sarkar P; Datta C; Pal DK; Saha A; Ghosh A
Pathol Res Pract; 2024 Jan; 253():154970. PubMed ID: 38056136
[TBL] [Abstract][Full Text] [Related]
28. TET2 mutations in acute myeloid leukemia (AML): results from a comprehensive genetic and clinical analysis of the AML study group.
Gaidzik VI; Paschka P; Späth D; Habdank M; Köhne CH; Germing U; von Lilienfeld-Toal M; Held G; Horst HA; Haase D; Bentz M; Götze K; Döhner H; Schlenk RF; Bullinger L; Döhner K
J Clin Oncol; 2012 Apr; 30(12):1350-7. PubMed ID: 22430270
[TBL] [Abstract][Full Text] [Related]
29. The Role of the
Chen SL; Qin ZY; Hu F; Wang Y; Dai YJ; Liang Y
Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31426381
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of
Liu Y; Zhang J; Du Z; Huang J; Cheng Y; Yi W; Li T; Yang J; Chen C
Front Genet; 2022; 13():1087938. PubMed ID: 36699453
[No Abstract] [Full Text] [Related]
31. Increased 5-hydroxymethylcytosine and Ten-eleven Translocation Protein Expression in Ultraviolet B-irradiated HaCaT Cells.
Wang D; Huang JH; Zeng QH; Gu C; Ding S; Lu JY; Chen J; Yang SB
Chin Med J (Engl); 2017 Mar; 130(5):594-599. PubMed ID: 28229992
[TBL] [Abstract][Full Text] [Related]
32. BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation.
Raffel S; Falcone M; Kneisel N; Hansson J; Wang W; Lutz C; Bullinger L; Poschet G; Nonnenmacher Y; Barnert A; Bahr C; Zeisberger P; Przybylla A; Sohn M; Tönjes M; Erez A; Adler L; Jensen P; Scholl C; Fröhling S; Cocciardi S; Wuchter P; Thiede C; Flörcken A; Westermann J; Ehninger G; Lichter P; Hiller K; Hell R; Herrmann C; Ho AD; Krijgsveld J; Radlwimmer B; Trumpp A
Nature; 2017 Nov; 551(7680):384-388. PubMed ID: 29144447
[TBL] [Abstract][Full Text] [Related]
33. Loss of TET2 with reduced genomic 5-hmC is associated with adverse-risk AML.
Pethusamy K; Seethy A; Dhar R; Karmakar A; Chaudhary S; Bakhshi S; Palanichamy JK; Chopra A; Chauhan SS; Karmakar S
Leuk Lymphoma; 2022 Dec; 63(14):3426-3432. PubMed ID: 36165590
[TBL] [Abstract][Full Text] [Related]
34. [Clinical significance of TET2 gene expression in 157 adult acute myeloid leukemia patients with normal cytogenetics].
Zhu Z; Chen J; Yu M; Chen F; Chen Z; Lou J; Tong H; Huang J; Qian W; Meng H; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2014 Sep; 35(9):802-7. PubMed ID: 25246247
[TBL] [Abstract][Full Text] [Related]
35. Role of TET dioxygenases in the regulation of both normal and pathological hematopoiesis.
Joshi K; Zhang L; Breslin S J P; Kini AR; Zhang J
J Exp Clin Cancer Res; 2022 Oct; 41(1):294. PubMed ID: 36203205
[TBL] [Abstract][Full Text] [Related]
36. The prognostic role of C-KIT, TET1 and TET2 gene expression in Acute Myeloid Leukemia.
Nabil R; Hassan NM; Abdellateif MS; Gawdat RM; Elshazly SS
Mol Biol Rep; 2023 Jan; 50(1):641-653. PubMed ID: 36371552
[TBL] [Abstract][Full Text] [Related]
37. The prognostic value of RASGEF1A RNA expression and DNA methylation in cytogenetically normal acute myeloid leukemia.
He X; Zhang W; Fu W; Liu X; Yang P; Wang J; Zhu M; Li S; Zhang W; Zhang X; Dong G; Yan C; Zhao Y; Zeng Z; Jing H
Cancer Biomark; 2023; 36(2):103-116. PubMed ID: 36404533
[TBL] [Abstract][Full Text] [Related]
38. Expression and role of nuclear receptor-interacting protein 1 (NRIP1) in stomach adenocarcinoma.
Fang D; Lu G
Ann Transl Med; 2020 Oct; 8(20):1293. PubMed ID: 33209873
[TBL] [Abstract][Full Text] [Related]
39.
Pasca S; Jurj A; Tomuleasa C; Zdrenghea M
Medicina (Kaunas); 2020 Nov; 56(12):. PubMed ID: 33255417
[No Abstract] [Full Text] [Related]
40. High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts.
Wang J; Li F; Ma Z; Yu M; Guo Q; Huang J; Yu W; Wang Y; Jin J
EBioMedicine; 2018 Feb; 28():90-96. PubMed ID: 29402726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
